295 related articles for article (PubMed ID: 27869651)
1. Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury.
Leaf IA; Nakagawa S; Johnson BG; Cha JJ; Mittelsteadt K; Guckian KM; Gomez IG; Altemeier WA; Duffield JS
J Clin Invest; 2017 Jan; 127(1):321-334. PubMed ID: 27869651
[TBL] [Abstract][Full Text] [Related]
2. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease].
Nakagawa S
Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
4. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
[TBL] [Abstract][Full Text] [Related]
5. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis: Pericyte MyD88 and IRAK4 signalling in fibrosis.
Allison SJ
Nat Rev Nephrol; 2017 Feb; 13(2):63. PubMed ID: 27916973
[No Abstract] [Full Text] [Related]
7. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-32α production is regulated by MyD88-dependent and independent pathways in IL-1β-stimulated human alveolar epithelial cells.
Ko NY; Mun SH; Lee SH; Kim JW; Kim DK; Kim HS; Her E; Kim SH; Won HS; Shin HS; Kim HS; Kim YM; Choi WS
Immunobiology; 2011; 216(1-2):32-40. PubMed ID: 20430472
[TBL] [Abstract][Full Text] [Related]
9. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway.
Wang YC; Chen Q; Luo JM; Nie J; Meng QH; Shuai W; Xie H; Xia JM; Wang H
Exp Mol Med; 2019 Mar; 51(3):1-11. PubMed ID: 30902967
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional characterization of IRAK4 in large yellow croaker (Larimichthys crocea) that associates with MyD88 but impairs NF-κB activation.
Zou PF; Huang XN; Yao CL; Sun QX; Li Y; Zhu Q; Yu ZX; Fan ZJ
Fish Shellfish Immunol; 2017 Apr; 63():452-464. PubMed ID: 27989863
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1
Lemos DR; McMurdo M; Karaca G; Wilflingseder J; Leaf IA; Gupta N; Miyoshi T; Susa K; Johnson BG; Soliman K; Wang G; Morizane R; Bonventre JV; Duffield JS
J Am Soc Nephrol; 2018 Jun; 29(6):1690-1705. PubMed ID: 29739813
[No Abstract] [Full Text] [Related]
12. LPS-Binding Protein Modulates Acute Renal Fibrosis by Inducing Pericyte-to-Myofibroblast Trans-Differentiation through TLR-4 Signaling.
Castellano G; Stasi A; Franzin R; Sallustio F; Divella C; Spinelli A; Netti GS; Fiaccadori E; Cantaluppi V; Crovace A; Staffieri F; Lacitignola L; Grandaliano G; Simone S; Pertosa GB; Gesualdo L
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357597
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
14. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice.
Li F; Han F; Li H; Zhang J; Qiao X; Shi J; Yang L; Dong J; Luo M; Wei J; Liu X
Mol Immunol; 2017 Oct; 90():11-21. PubMed ID: 28662409
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.
Vollmer S; Strickson S; Zhang T; Gray N; Lee KL; Rao VR; Cohen P
Biochem J; 2017 Jun; 474(12):2027-2038. PubMed ID: 28512203
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
17. Defective MyD88 and IRAK4 but not TLR-2 expression in HIV+ individuals with latent tuberculosis infection.
Devalraju KP; Neela VSK; Gaddam R; Chaudhury A; Van A; Krovvidi SS; Vankayalapati R; Valluri VL
Cytokine; 2018 Oct; 110():213-221. PubMed ID: 29778672
[TBL] [Abstract][Full Text] [Related]
18. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Kelly PN; Romero DL; Yang Y; Shaffer AL; Chaudhary D; Robinson S; Miao W; Rui L; Westlin WF; Kapeller R; Staudt LM
J Exp Med; 2015 Dec; 212(13):2189-201. PubMed ID: 26621451
[TBL] [Abstract][Full Text] [Related]
19. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.
Ahmad R; Sylvester J; Zafarullah M
Cell Signal; 2007 Dec; 19(12):2549-57. PubMed ID: 17905570
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-36α Induces Inflammatory Mediators From Human Pancreatic Myofibroblasts Via a MyD88 Dependent Pathway.
Nishida A; Inatomi O; Fujimoto T; Imaeda H; Tani M; Andoh A
Pancreas; 2017 Apr; 46(4):539-548. PubMed ID: 28099250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
